Patents by Inventor Patrick Michael Smith

Patrick Michael Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240390471
    Abstract: The invention relates to novel compounds and formulations. Further, the invention relates to novel compounds and formulations useful in pneumococcal and pneumococcal conjugate vaccines. More specifically, the invention relates to compositions comprising pneumococcal conjugates and one or more compounds of Formula I, Ia, II, IIa, III, IIIa, IV, or IVa, or a pharmaceutically acceptable salt thereof, prepared as stable nanoemulsions (herein referred to as “SNE adjuvant compositions” or “SNEs”).
    Type: Application
    Filed: May 16, 2024
    Publication date: November 28, 2024
    Applicant: Merck Sharp & Dohme LLC
    Inventors: Patrick L. Ahl, Peter J. Manley, Izzat T. Raheem, W. Michael Seganish, William J. Smith
  • Publication number: 20240317847
    Abstract: The present invention is related to agents capable of binding to and inhibiting or antagonizing the action of IL-11 and/or IL-11RA for the treatment and/or prevention of abnormal uterine bleeding, which comprises heavy menstrual bleeding, prolonged bleeding, altered bleeding pattern, dysmenorrhea, as well as of the underlying diseases leiomyoma and endometriosis and the use of the agent to inhibit menstruation. Furthermore, the invention provides novel IL-11 antibodies.
    Type: Application
    Filed: February 24, 2022
    Publication date: September 26, 2024
    Applicant: BAYER AKTIENGESELLSCHAFT
    Inventors: Maik Stefan Wilhelm OBENDORF, Frank SACHER, Jörg MÜLLER, Ralf LESCHE, Christian VOTSMEIER, Stephan MÄRSCH, Jan TEBBE, Philipp ELLINGER, Patrick Michael SMITH, Jenny FITTING, Katharina FILARSKY, Mathias GEHRMANN, Marcus KARLSTETTER, Ernst WEBER, Mark TRAUTWEIN
  • Publication number: 20240124572
    Abstract: The present invention is related to agents capable of binding to and inhibiting or antagonizing the action of IL-11 and/or or IL-11RA for the treatment and/or prevention of abnormal uterine bleeding, which comprises heavy menstrual bleeding, prolonged bleeding, altered bleeding pattern, dysmenorrhea, as well as of the underlying diseases leiomyoma and endometriosis and the use of the agent to inhibit menstruation. Furthermore, the invention provides novel IL-11 antibodies.
    Type: Application
    Filed: February 24, 2022
    Publication date: April 18, 2024
    Inventors: Maik Stefan Wilhelm OBENDORF, Frank SACHER, Jörg MÜLLER, Ralf LESCHE, Christian VOTSMEIER, Stephan MÄRSCH, Jan TEBBE, Philipp ELLINGER, Patrick Michael SMITH, Jenny FITTING, Katharina FILARSKY, Mathias GEHRMANN, Marcus KARLSTETTER, Ernst WEBER, Mark TRAUTWEIN
  • Publication number: 20120117892
    Abstract: The objective of this invention is to provide ease of application for steel armored joints used in industrial concrete floor construction. It provides one step simple and precise installation. Provides a substrate for joint filler compression. Eliminates the need for wood forms and field welding that produces waste. Elevation adjustment and the ease thereof are achieved by vertical slots cut in the upright. The neoprene bolts are to be tightened when the steel is at the desired elevation. Two part armored joints separate as the concrete contracts during the curing process. Then the joint filler product is applied and retained in a permanent encased condition.
    Type: Application
    Filed: November 15, 2010
    Publication date: May 17, 2012
    Inventor: Patrick Michael Smith